Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Céline Delucinge‐Vivier"'
Autor:
Marloes Zoetemelk, George M. Ramzy, Magdalena Rausch, Thibaud Koessler, Judy R. vanBeijnum, Andrea Weiss, Valentin Mieville, Sander R. Piersma, Richard R. deHaas, Céline Delucinge‐Vivier, Axel Andres, Christian Toso, Alexander A. Henneman, Simone Ragusa, Tatiana V. Petrova, Mylène Docquier, Thomas A. McKee, Connie R. Jimenez, Youssef Daali, Arjan W. Griffioen, Laura Rubbia‐Brandt, Pierre‐Yves Dietrich, Patrycja Nowak‐Sliwinska
Publikováno v:
Molecular Oncology, Vol 14, Iss 11, Pp 2894-2919 (2020)
The current standard of care for colorectal cancer (CRC) is a combination of chemotherapeutics, often supplemented with targeted biological drugs. An urgent need exists for improved drug efficacy and minimized side effects, especially at late‐stage
Externí odkaz:
https://doaj.org/article/95a558b6cae1422989a521f96cb74001
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9418 (2010)
BACKGROUND: Cellular contact with stimulated T cells is a potent inducer of cytokine production in human monocytes and is likely to play a substantial part in chronic/sterile inflammatory diseases. High-density lipoproteins (HDL) specifically inhibit
Externí odkaz:
https://doaj.org/article/8bfc7b89f21a4c05bcc0821b8ff8c1a0
Autor:
Benoit Terris, Gilles Mentha, Pietro E. Majno, Bertand Dousset, Patrick Descombes, Céline Delucinge-Vivier, Catherine Brezault, Sébastien Tauzin, Laura Rubbia-Brandt
Supplementary Tables 1-7 from Gene Expression Profiling Provides Insights into Pathways of Oxaliplatin-Related Sinusoidal Obstruction Syndrome in Humans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946c1f5b25ce261e1f170659f2236c39
https://doi.org/10.1158/1535-7163.22502212
https://doi.org/10.1158/1535-7163.22502212
Autor:
Matthias Christian Vogg, Jaroslav Ferenc, Wanda Christa Buzgariu, Chrystelle Perruchoud, Paul Gerald Layague Sanchez, Leonardo Beccari, Clara Nuninger, Youn Le Cras, Céline Delucinge-Vivier, Panagiotis Papasaikas, Stéphane Vincent, Brigitte Galliot, Charisios D. Tsiairis
Publikováno v:
Science Advances. 8
The molecular mechanisms that maintain cellular identities and prevent dedifferentiation or transdifferentiation remain mysterious. However, both processes are transiently used during animal regeneration. Therefore, organisms that regenerate their or
Autor:
George M. Ramzy, Laura Boschung, Thibaud Koessler, Céline Delucinge-Vivier, Mylène Docquier, Thomas A. McKee, Laura Rubbia-Brandt, Patrycja Nowak-Sliwinska
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4812
FOLFOXIRI, i.e., the combination of folinic acid, 5-fluorouracil, oxaliplatin, and irinotecan, is a first-line treatment for colorectal carcinoma (CRC), yet non-personalized and aggressive. In this study, to mimic the clinical situation of patients d
Autor:
Andrea Weiss, Connie R. Jimenez, Patrycja Nowak-Sliwinska, Pierre-Yves Dietrich, Alexander A. Henneman, Marloes Zoetemelk, Mylène Docquier, Youssef Daali, Thibaud Koessler, Magdalena Rausch, Céline Delucinge-Vivier, Thomas Alexander Mckee, Axel Andres, Christian Toso, Tatiana V. Petrova, Richard R. de Haas, Simone Ragusa, Sander R. Piersma, George Mourad Ramzy, Arjan W. Griffioen, Valentin Mieville, Laura Rubbia-Brandt, Judy R. van Beijnum
Publikováno v:
Molecular Oncology
Molecular oncology, vol. 14, no. 11, pp. 2894-2919
Molecular Oncology (2020)
Zoetemelk, M, Ramzy, G M, Rausch, M, Koessler, T, van Beijnum, J R, Weiss, A, Mieville, V, Piersma, S R, de Haas, R R, Delucinge-Vivier, C L, Andres, A, Toso, C, Henneman, A A, Ragusa, S, Petrova, T V, Docquier, M, McKee, T A, Jimenez, C R, Daali, Y, Griffioen, A W, Rubbia-Brandt, L, Dietrich, P-Y & Nowak-Sliwinska, P 2020, ' Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment ', Molecular oncology, vol. 14, no. 11, pp. 2894-2919 . https://doi.org/10.1002/1878-0261.12797
Molecular oncology, 14(11), 2894-2919. Elsevier
Molecular Oncology, Vol 14, Iss 11, Pp 2894-2919 (2020)
Molecular oncology, vol. 14, no. 11, pp. 2894-2919
Molecular Oncology (2020)
Zoetemelk, M, Ramzy, G M, Rausch, M, Koessler, T, van Beijnum, J R, Weiss, A, Mieville, V, Piersma, S R, de Haas, R R, Delucinge-Vivier, C L, Andres, A, Toso, C, Henneman, A A, Ragusa, S, Petrova, T V, Docquier, M, McKee, T A, Jimenez, C R, Daali, Y, Griffioen, A W, Rubbia-Brandt, L, Dietrich, P-Y & Nowak-Sliwinska, P 2020, ' Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment ', Molecular oncology, vol. 14, no. 11, pp. 2894-2919 . https://doi.org/10.1002/1878-0261.12797
Molecular oncology, 14(11), 2894-2919. Elsevier
Molecular Oncology, Vol 14, Iss 11, Pp 2894-2919 (2020)
Therapeutically guided multidrug optimization (TGMO) technology, composed of experimental testing and in silico modelling, allowed identification of synergistic and selective low‐dose optimized drug combinations (ODCs) active in multiple colorectal
Autor:
Matthias Christian Vogg, Jaroslav Ferenc, Wanda Christa Buzgariu, Chrystelle Perruchoud, Panagiotis Papasaikas, Paul Gerald Layague Sanchez, Clara Nuninger, Céline Delucinge-Vivier, Christine Rampon, Leonardo Beccari, Sophie Vriz, Stéphane Vincent, Brigitte Galliot, Charisios D. Tsiairis
The molecular mechanisms that maintain cell identities and prevent transdifferentiation remain mysterious. Interestingly, both dedifferentiation and transdifferentiation are transiently reshuffled during regeneration. Therefore, organisms that regene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9053591bd88d8801852f4012403a8b13
https://doi.org/10.1101/2021.12.22.473838
https://doi.org/10.1101/2021.12.22.473838
Autor:
Adriano Rutz, Magdalena Rausch, Mylène Docquier, Jean-Luc Wolfender, Olivier Dormond, Pierre-Marie Allard, Céline Delucinge-Vivier, Patrycja Nowak-Sliwinska
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 6467, p 6467 (2021)
Volume 22
Issue 12
International journal of molecular sciences, vol. 22, no. 12, pp. 6467
International journal of molecular sciences, Vol. 22, No 12 (2021) P. 6467
International Journal of Molecular Sciences, Vol 22, Iss 6467, p 6467 (2021)
Volume 22
Issue 12
International journal of molecular sciences, vol. 22, no. 12, pp. 6467
International journal of molecular sciences, Vol. 22, No 12 (2021) P. 6467
Resistance in clear cell renal cell carcinoma (ccRCC) against sunitinib is a multifaceted process encompassing numerous molecular aberrations. This induces clinical complications, reducing the treatment success. Understanding these aberrations helps
Autor:
Adriano Rutz, Mylène Docquier, Pierre-Marie Allard, Jean-Luc Wolfender, Magdalena Rausch, Olivier Dormond, Céline Delucinge-Vivier, Patrycja Nowak-Sliwinska, Paul J. Dyson
Publikováno v:
Cancers, Vol. 13, No 16 (2021) P. 3978
Cancers, Vol 13, Iss 3978, p 3978 (2021)
Cancers
Volume 13
Issue 16
Cancers, vol. 13, no. 16, pp. 3978
Cancers, Vol 13, Iss 3978, p 3978 (2021)
Cancers
Volume 13
Issue 16
Cancers, vol. 13, no. 16, pp. 3978
Simple Summary In this study, drug combination screening was used to design a multidrug combination consisting of repurposed drugs to treat sunitinib-resistant clear cell renal cell carcinoma. In the frame of this project, the multidrug combination h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5936e885df2447dbffe8d07660e3768
https://archive-ouverte.unige.ch/unige:159107
https://archive-ouverte.unige.ch/unige:159107
Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism
Autor:
Céline Delucinge-Vivier, Electron Kebebew, Samira M. Sadowski, Marie-Claude Brulhart-Meynet, Frédéric Triponez, Marc Pusztaszeri, Jonathan Sobel, Claudio De Vito, Volodymyr Petrenko, Charna Dibner, Jacques Philippe, Romano Regazzi
Publikováno v:
Journal of Clinical Endocrinology and Metabolism (2018)
Context Hyperparathyroidism is associated with hypercalcemia and the excess of parathyroid hormone secretion; however, the alterations in molecular pattern of functional genes during parathyroid tumorigenesis have not been unraveled. We aimed at esta